Oncogenes as Novel Targets for Cancer Therapy (Part II): Intermediate Signaling Molecules

By Zhang Zhuo   Li Mao   Rayburn Elizabeth R.   Hill Donald L.   Zhang Ruiwen   Wang Hui  

American Journal of PharmacoGenomics, Vol. 5, Iss. 4, 2005-01 ,pp. : 247-257

Adis International

Access to resources Recommend Favorite

Oncogenes as Novel Targets for Cancer Therapy (Part III): Transcription Factors

By Zhang Zhuo   Li Mao   Rayburn Elizabeth R.   Hill Donald L.   Zhang Ruiwen   Wang Hui  

American Journal of PharmacoGenomics, Vol. 5, Iss. 5, 2005-01 ,pp. : 327-338

Adis International

Access to resources Recommend Favorite

Oncogenes as Novel Targets for Cancer Therapy (Part I): Growth Factors and Protein Tyrosine Kinases

By Zhang Zhuo   Li Mao   Rayburn Elizabeth R.   Hill Donald L.   Zhang Ruiwen   Wang Hui  

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 173-190

Adis International

Access to resources Recommend Favorite

Molecular targets for cell cycle inhibition and cancer therapy

By Lee Mong-Hong   Yang Heng-Yin  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 329-346

Informa Healthcare

Access to resources Recommend Favorite

Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part II: targeting cell cycle events, caspases, NF-κB and the proteasome

By Hiss Donavon C   Gabriels Gary A  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 907-921

Informa Healthcare

Access to resources Recommend Favorite